购物车
- 全部删除
- 您的购物车当前为空
BC-23 (NSC 45382) 是一种有效的蛋白酶体抑制剂,具有抗肿瘤和抗菌活性。BC-23 抑制蛋白酶体的 CT-L 活性,可用于研究白血病,淋巴瘤,神经胶质瘤,乳腺癌和小细胞肺癌。
为众多的药物研发团队赋能,
让新药发现更简单!
BC-23 (NSC 45382) 是一种有效的蛋白酶体抑制剂,具有抗肿瘤和抗菌活性。BC-23 抑制蛋白酶体的 CT-L 活性,可用于研究白血病,淋巴瘤,神经胶质瘤,乳腺癌和小细胞肺癌。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 786 | 6-8周 | |
5 mg | ¥ 1,990 | 6-8周 | |
10 mg | ¥ 3,180 | 6-8周 | |
25 mg | ¥ 5,130 | 6-8周 | |
50 mg | ¥ 6,930 | 6-8周 | |
100 mg | ¥ 9,550 | 6-8周 |
产品描述 | BC-23 (NSC 45382) is a potent proteasome inhibitor with antitumor and antimicrobial activity.BC-23 inhibits the CT-L activity of the proteasome and is used in the study of leukemias, lymphomas, gliomas, breast cancer, and small cell lung cancer. |
别名 | NSC-45382, NSC45382, NSC 45382, BC23, BC 23 |
分子量 | 439.87 |
分子式 | C21H14ClN3O4S |
CAS No. | 6298-15-3 |
Smiles | O=C1C=2C(C(=O)C(Cl)=C1NC3=CC=C(S(NC4=CC=CC=N4)(=O)=O)C=C3)=CC=CC2 |
密度 | 1.56 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 20 mg/mL (45.47 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容